University of Texas at Austin, Department of Chemistry and Biochemistry, 105 E 24th St., Welch Hall A5300, Austin, TX 78712-1165, USA.
Nat Prod Rep. 2014 Apr;31(4):504-13. doi: 10.1039/c3np70076c. Epub 2014 Feb 11.
Despite the longstanding importance of polyketide natural products in human medicine, nearly all commercial polyketide-based drugs are prepared through fermentation or semi-synthesis. The paucity of manufacturing routes involving de novo chemical synthesis reflects the inability of current methods to concisely address the preparation of these complex structures. Direct alcohol C-H bond functionalization via"C-C bond forming transfer hydrogenation" provides a powerful, new means of constructing type I polyketides that bypasses stoichiometric use of chiral auxiliaries, premetallated C-nucleophiles, and discrete alcohol-to-aldehyde redox reactions. Using this emergent technology, total syntheses of 6-deoxyerythronolide B, bryostatin 7, trienomycins A and F, cyanolide A, roxaticin, and formal syntheses of rifamycin S and scytophycin C, were accomplished. These syntheses represent the most concise routes reported to any member of the respective natural product families.
尽管聚酮天然产物在人类医学中一直具有重要意义,但几乎所有商业化的聚酮类药物都是通过发酵或半合成制备的。涉及从头化学合成的制造途径很少,这反映了当前方法无法简洁地制备这些复杂结构。通过“C-C 键形成转移氢化”进行直接醇 C-H 键功能化,为构建 I 型聚酮类化合物提供了一种强大的新方法,该方法绕过了手性助剂、预金属化 C-亲核试剂和离散的醇醛氧化还原反应的化学计量使用。使用这项新兴技术,完成了 6-脱氧赤藓醇 B、Bryostatin 7、Trienomycins A 和 F、Cyanolide A、Roxaticin 以及 Rifamycin S 和 Scytophycin C 的全合成。这些合成代表了各自天然产物家族中报道的最简洁路线。